Halperin Wernli Miri
SEC CIK 1897615 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | Executive Pres, Dir | 202.4K | — | — | 5 | 2022-03-24 | 2024-08-21 |
Most active insiders at DFTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barrow Robert | CEO, Dir | — | $3.08M |
| 2 | Sullivan Mark | CLO | — | $1.04M |
| 3 | Karlin Daniel | Chief Medical Off | — | $748.9K |
| 4 | Roberts Brandi | CFO | — | $135.7K |
| 5 | Wiley Matthew T. | Chief Commercial Off | — | $129.1K |
| 6 | Adsett Roger | Dir | — | — |
| 7 | CRYSTAL ROGER | Dir | — | — |
| 8 | Bruhn Suzanne Louise | Dir | — | — |
| 9 | Krebs Andreas | Dir | — | — |
| 10 | Vallone Carol A | Dir | — | — |
Halperin Wernli Miri made no open-market trades at DFTX in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-22 | 2024-08-21 | DFTX | Definium Therapeutics, Inc. | Halperin Wernli Miri | Executive Pres | F - Tax | $6.17 | -32.6K | 202.4K | -14% | -$201.1K |
| D | 2024-08-22 | 2024-08-21 | DFTX | Definium Therapeutics, Inc. | Halperin Wernli Miri | Executive Pres | M - OptEx | $3.70 | +50.0K | 235.0K | +27% | +$185.0K |
| A | 2023-04-24 | 2023-03-14 | DFTX | Definium Therapeutics, Inc. | Wernli Miri Halperin | Executive Pres, Dir | A - Grant | $0.00 | +100.0K | 185.0K | +118% | $0 |
| 2023-03-17 | 2023-03-14 | DFTX | Definium Therapeutics, Inc. | Wernli Miri Halperin | Executive Pres, Dir | A - Grant | $0.00 | +100.0K | 1.38M | +8% | $0 | |
| D | 2022-03-28 | 2022-03-24 | DFTX | Definium Therapeutics, Inc. | Wernli Miri Halperin | Executive Pres, Dir | A - Grant | $0.00 | +600.0K | 1.27M | +89% | $0 |
Purchase Sale Sale after option exercise All abbreviations